NCT02788409View on ClinicalTrials.gov

Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US

CompletedOBSERVATIONAL
Enrollment

2,234

Participants

Timeline

Start Date

May 15, 2016

Primary Completion Date

May 9, 2018

Study Completion Date

May 9, 2018

Conditions
Prostatic Neoplasms
Interventions
OTHER

Not applicable for study

Provide external perspective on background second primary cancer incidence rates for REASSURE study.

Trial Locations (1)

Unknown

Waltham

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
collaborator

RTI Health Solutions

OTHER

lead

Bayer

INDUSTRY

NCT02788409 - Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US | Biotech Hunter | Biotech Hunter